VivePeptides logo

Research Collection

Peptides for Fat Burning

Peptides investigated in the context of lipolysis, mitochondrial energy expenditure, and substrate utilization.

Peptides for Fat Burning are research compounds studied for their roles in metabolic regulation, lipid mobilization, and growth hormone axis signaling, spanning mitochondrial-derived peptides, growth hormone-releasing hormone analogs, and hGH fragment peptides such as MOTS-c, Tesamorelin, and AOD-9604, offered strictly for laboratory and in vitro research use.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

MOTS-c research peptide vial

MOTS-c

$75.00View
Tesamorelin research peptide vial

Tesamorelin

$69.00View
AOD-9604 research peptide vial

AOD-9604

$65.00View

Research Overview

Fat Metabolism Research: A Multi-Mechanism Category

This collection encompasses peptides investigated for their involvement in energy metabolism, adipose tissue signaling, and growth hormone-mediated lipid mobilization. Fat metabolism research remains an active area of investigation because these pathways intersect mitochondrial bioenergetics, the somatotropic axis, and receptor-mediated lipolysis, each offering a distinct mechanistic entry point for preclinical study.

Three mechanism classes are represented here: MOTS-c, a mitochondrial-derived peptide studied for its role in metabolic homeostasis and cellular energy sensing; Tesamorelin, a growth hormone-releasing hormone (GHRH) analog studied for its stimulation of endogenous growth hormone secretion; and AOD-9604, a modified fragment of human growth hormone studied for its structure-specific relationship to lipid metabolism pathways without the full growth-promoting sequence. VivePeptides sources and documents each compound to research-grade purity standards, with batch-specific analytical data provided so investigators can verify identity and purity before designing experiments.

Three Distinct Mechanism Classes

This collection spans mitochondrial-derived peptide signaling, GHRH receptor agonism, and hGH fragment-based pathways, giving researchers mechanistically distinct tools for metabolic study designs.

Verified Purity and Documentation

Each compound ships with batch-specific analytical documentation so laboratories can confirm identity and purity prior to experimental use.

Choosing By Research Objective

Investigators typically select MOTS-c for mitochondrial and cellular energy models, Tesamorelin for growth hormone axis studies, and AOD-9604 for fragment-specific lipolysis research.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
MOTS-cMitochondrial-derived peptideCellular energy metabolism, mitochondrial signalingEncoded within mitochondrial genome
TesamorelinGHRH analogGrowth hormone axis, pulsatile GH releaseStabilized GHRH receptor-binding structure
AOD-9604hGH fragment (176-191)Lipolysis-associated fragment researchLacks growth-promoting hGH domain

Mechanism & Research Context

Mechanism Classes and What the Literature Shows

The mechanism classes represented in this collection are distinguished by where they intervene in metabolic signaling, ranging from intracellular mitochondrial pathways to receptor-mediated endocrine release. Preclinical literature has examined MOTS-c in models of mitochondrial dysfunction and metabolic stress, where it has been studied as a regulator of nuclear gene expression under energetic challenge.

Tesamorelin has been examined in the context of GHRH receptor binding and pulsatile growth hormone release, with research literature focused on downstream lipid mobilization associated with the growth hormone/IGF-1 axis. AOD-9604 research has centered on the C-terminal fragment of growth hormone, isolating lipolytic-associated structural regions from the growth-promoting domain.

Researchers selecting between these compounds typically weigh mechanism specificity, receptor targets, and whether a mitochondrial, endocrine, or fragment-based model best fits the experimental question. Study design considerations include vehicle selection, storage stability, and reconstitution protocols appropriate to each peptide's structure.

Research FAQ

Frequently asked questions

What is MOTS-c and how does it relate to fat metabolism research?

MOTS-c is a mitochondrial-derived peptide encoded by a short open reading frame within the mitochondrial genome, studied for its role in regulating cellular energy metabolism and metabolic stress responses. Preclinical literature has examined its involvement in AMPK pathway activation and nuclear gene expression under energetic challenge. Research has also investigated its behavior across different tissue and exercise-stress models. It is offered here strictly for laboratory research use.

How does Tesamorelin differ mechanistically from AOD-9604?

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog studied for its stimulation of endogenous growth hormone secretion through pituitary receptor binding, while AOD-9604 is a fragment of the human growth hormone molecule studied for structural features linked to lipid metabolism pathways independent of the full growth-promoting sequence. The two compounds therefore represent distinct mechanism classes, an upstream endocrine signal versus a downstream structural fragment. Researchers often select between them based on whether the experimental model targets the growth hormone axis broadly or a narrower structural region.

What research models have examined peptides in this collection for fat metabolism?

Preclinical models in this collection have examined mitochondrial function, adipose tissue signaling, and growth hormone-mediated lipid pathways, most often in cell culture and animal research models rather than clinical settings. MOTS-c research has focused on cellular energy sensing and metabolic stress models, Tesamorelin research has examined growth hormone secretion dynamics, and AOD-9604 research has centered on fragment-specific lipolytic signaling. These remain distinct, compound-specific lines of preclinical investigation.

Is AOD-9604 the same as human growth hormone?

No, AOD-9604 is a modified fragment corresponding to amino acids 176 to 191 of the human growth hormone sequence, not the full hormone molecule. Research has focused on this fragment because it appears to isolate structural regions associated with lipid metabolism while excluding the growth-promoting domain of the intact hormone. This distinction is central to why AOD-9604 is studied as a separate research compound rather than as growth hormone itself.

How should researchers select between MOTS-c, Tesamorelin, and AOD-9604 for a study?

Compound selection depends on the specific mechanism class relevant to the research question, mitochondrial signaling for MOTS-c, growth hormone axis activity for Tesamorelin, or fragment-specific lipolytic structure for AOD-9604. Researchers should also account for each peptide's stability profile, reconstitution requirements, and available analytical documentation when designing a study. Reviewing the mechanism class comparison alongside batch-specific certificates of analysis is recommended before finalizing experimental design.

What purity and documentation standards apply to fat metabolism research peptides at VivePeptides?

VivePeptides sources each compound in this collection to research-grade purity standards and provides batch-specific analytical documentation, including identity and purity verification, for every peptide listed. This documentation allows laboratories to confirm compound integrity prior to experimental use. All products in this collection are intended strictly for laboratory and in vitro research purposes, not for human or animal administration.

Related Research Collections

Continue exploring

Peptides for Weight LossGLP-1 PeptidesPeptides for Muscle GrowthGrowth Hormone Peptides

These products are sold strictly for laboratory and research use only and are not approved for human consumption, diagnosis, or therapeutic treatment. Not for human or veterinary use. These statements have not been evaluated by the Food and Drug Administration, and nothing on this page constitutes medical advice or a health claim.